vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and PAR TECHNOLOGY CORP (PAR). Click either name above to swap in a different company.

PAR TECHNOLOGY CORP is the larger business by last-quarter revenue ($120.1M vs $62.1M, roughly 1.9× Cytek Biosciences, Inc.). On growth, PAR TECHNOLOGY CORP posted the faster year-over-year revenue change (14.4% vs 8.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-12.5M). Over the past eight quarters, PAR TECHNOLOGY CORP's revenue compounded faster (30.9% CAGR vs 17.7%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

PAR Technology Corp is a global provider of point-of-sale systems, restaurant management software, and integrated tech solutions. Its core segments serve food service, hospitality, and government security markets, offering cloud tools to streamline operations, enhance customer experiences, and boost efficiency for enterprise and small-to-medium clients.

CTKB vs PAR — Head-to-Head

Bigger by revenue
PAR
PAR
1.9× larger
PAR
$120.1M
$62.1M
CTKB
Growing faster (revenue YoY)
PAR
PAR
+6.3% gap
PAR
14.4%
8.1%
CTKB
More free cash flow
CTKB
CTKB
$10.8M more FCF
CTKB
$-1.8M
$-12.5M
PAR
Faster 2-yr revenue CAGR
PAR
PAR
Annualised
PAR
30.9%
17.7%
CTKB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
PAR
PAR
Revenue
$62.1M
$120.1M
Net Profit
$-44.1M
Gross Margin
52.9%
41.2%
Operating Margin
-9.0%
-15.0%
Net Margin
-70.9%
Revenue YoY
8.1%
14.4%
Net Profit YoY
-557.1%
EPS (diluted)
$-0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
PAR
PAR
Q4 25
$62.1M
$120.1M
Q3 25
$52.3M
$119.2M
Q2 25
$45.6M
$112.4M
Q1 25
$41.5M
$103.9M
Q4 24
$57.5M
$105.0M
Q3 24
$51.5M
$96.8M
Q2 24
$46.6M
$78.2M
Q1 24
$44.9M
$70.1M
Net Profit
CTKB
CTKB
PAR
PAR
Q4 25
$-44.1M
Q3 25
$-5.5M
$-18.2M
Q2 25
$-5.6M
$-21.0M
Q1 25
$-11.4M
$-24.4M
Q4 24
$9.6M
Q3 24
$941.0K
$-19.8M
Q2 24
$-10.4M
$54.2M
Q1 24
$-6.2M
$-18.3M
Gross Margin
CTKB
CTKB
PAR
PAR
Q4 25
52.9%
41.2%
Q3 25
52.7%
41.3%
Q2 25
52.3%
45.4%
Q1 25
48.6%
46.5%
Q4 24
58.5%
42.9%
Q3 24
56.3%
44.5%
Q2 24
54.6%
41.0%
Q1 24
51.3%
37.2%
Operating Margin
CTKB
CTKB
PAR
PAR
Q4 25
-9.0%
-15.0%
Q3 25
-17.6%
-14.8%
Q2 25
-23.3%
-15.4%
Q1 25
-36.1%
-15.2%
Q4 24
5.2%
-15.6%
Q3 24
-8.2%
-15.7%
Q2 24
-18.3%
-26.5%
Q1 24
-23.9%
-38.2%
Net Margin
CTKB
CTKB
PAR
PAR
Q4 25
-70.9%
Q3 25
-10.5%
-15.3%
Q2 25
-12.2%
-18.7%
Q1 25
-27.5%
-23.4%
Q4 24
16.8%
Q3 24
1.8%
-20.5%
Q2 24
-22.4%
69.3%
Q1 24
-13.8%
-26.1%
EPS (diluted)
CTKB
CTKB
PAR
PAR
Q4 25
$-0.52
Q3 25
$-0.45
Q2 25
$-0.52
Q1 25
$-0.60
Q4 24
$-0.56
Q3 24
$-0.56
Q2 24
$1.60
Q1 24
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
PAR
PAR
Cash + ST InvestmentsLiquidity on hand
$90.9M
$80.1M
Total DebtLower is stronger
$394.0M
Stockholders' EquityBook value
$341.7M
$825.1M
Total Assets
$461.5M
$1.4B
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
PAR
PAR
Q4 25
$90.9M
$80.1M
Q3 25
$93.3M
$93.0M
Q2 25
$75.5M
$85.7M
Q1 25
$95.3M
$92.2M
Q4 24
$98.7M
$108.6M
Q3 24
$162.3M
$118.4M
Q2 24
$177.9M
$142.5M
Q1 24
$168.8M
$72.5M
Total Debt
CTKB
CTKB
PAR
PAR
Q4 25
$394.0M
Q3 25
$393.4M
Q2 25
$392.8M
Q1 25
$392.3M
Q4 24
$368.4M
Q3 24
$466.7M
Q2 24
$378.7M
Q1 24
$378.2M
Stockholders' Equity
CTKB
CTKB
PAR
PAR
Q4 25
$341.7M
$825.1M
Q3 25
$378.6M
$838.0M
Q2 25
$377.6M
$859.1M
Q1 25
$379.6M
$852.0M
Q4 24
$395.7M
$871.7M
Q3 24
$385.5M
$692.7M
Q2 24
$389.1M
$588.3M
Q1 24
$392.6M
$526.4M
Total Assets
CTKB
CTKB
PAR
PAR
Q4 25
$461.5M
$1.4B
Q3 25
$494.9M
$1.4B
Q2 25
$493.3M
$1.4B
Q1 25
$482.6M
$1.4B
Q4 24
$499.5M
$1.4B
Q3 24
$491.2M
$1.3B
Q2 24
$483.7M
$1.1B
Q1 24
$492.1M
$1.0B
Debt / Equity
CTKB
CTKB
PAR
PAR
Q4 25
0.48×
Q3 25
0.47×
Q2 25
0.46×
Q1 25
0.46×
Q4 24
0.42×
Q3 24
0.67×
Q2 24
0.64×
Q1 24
0.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
PAR
PAR
Operating Cash FlowLast quarter
$-771.0K
$-11.8M
Free Cash FlowOCF − Capex
$-1.8M
$-12.5M
FCF MarginFCF / Revenue
-2.9%
-10.4%
Capex IntensityCapex / Revenue
1.6%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$-30.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
PAR
PAR
Q4 25
$-771.0K
$-11.8M
Q3 25
$-3.9M
$8.4M
Q2 25
$108.0K
$-6.6M
Q1 25
$-125.0K
$-17.2M
Q4 24
$2.0M
$3.4M
Q3 24
$13.2M
$8.8M
Q2 24
$6.2M
$-13.8M
Q1 24
$4.0M
$-23.6M
Free Cash Flow
CTKB
CTKB
PAR
PAR
Q4 25
$-1.8M
$-12.5M
Q3 25
$-4.6M
$7.0M
Q2 25
$-1.5M
$-7.4M
Q1 25
$-974.0K
$-17.6M
Q4 24
$1.1M
$3.2M
Q3 24
$12.2M
$8.4M
Q2 24
$5.2M
$-14.2M
Q1 24
$3.4M
$-23.6M
FCF Margin
CTKB
CTKB
PAR
PAR
Q4 25
-2.9%
-10.4%
Q3 25
-8.7%
5.9%
Q2 25
-3.2%
-6.6%
Q1 25
-2.3%
-16.9%
Q4 24
1.9%
3.0%
Q3 24
23.7%
8.7%
Q2 24
11.0%
-18.2%
Q1 24
7.6%
-33.7%
Capex Intensity
CTKB
CTKB
PAR
PAR
Q4 25
1.6%
0.7%
Q3 25
1.3%
1.1%
Q2 25
3.5%
0.7%
Q1 25
2.0%
0.4%
Q4 24
1.6%
0.2%
Q3 24
2.0%
0.4%
Q2 24
2.3%
0.5%
Q1 24
1.3%
0.1%
Cash Conversion
CTKB
CTKB
PAR
PAR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.21×
Q3 24
14.05×
Q2 24
-0.26×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

PAR
PAR

Subscription Service$76.1M63%
Hardware$27.8M23%
Professional Service$16.2M13%

Related Comparisons